Molecular Therapy Methods and Clinical Development
短名 | Mol. Ther. Methods Clin. Dev. |
Journal Impact | 4.43 |
国际分区 | MEDICINE, RESEARCH & EXPERIMENTAL(Q2) |
期刊索引 | SCI Q2中科院 2 区 |
ISSN | 2329-0501 |
h-index | 60 |
国内分区 | 医学(2区)医学医学研究与实验(2区) |
MOLECULAR THERAPY—METHODS & CLINICAL DEVELOPMENT 的目的是建立在 MOLECULAR THERAPY 在出版重要的同行评审方法和程序方面的成功的基础上,以及在分子治疗伞下广泛领域的转化进展。特别感兴趣的主题该期刊的范围包括:基因载体工程和生产、靶向基因组编辑和工程方法、细胞重编程和多能细胞定向分化的方法和技术开发、基因和细胞载体传递方法、生物材料和纳米粒子的开发在基因和细胞治疗和再生医学中的应用,基因和细胞载体的生物分布和追踪分析,新和下一代载体的药理学/毒理学研究,细胞分离、工程、培养、扩增和移植的方法,细胞加工、储存, 和银行用于治疗应用、临床前和 QC/QA 检测开发LOPMENT,转化和临床放大和良好制造程序和工艺开发,临床方案开发,用于分析、建模或生物数据可视化的计算和生物信息学方法,协商监管批准过程并获得此类临床试验批准。
期刊主页投稿网址涉及主题 | 生物遗传学化学生物化学医学基因内科学免疫学细胞生物学遗传增强重组DNA病理病毒学细胞培养内分泌学分子生物学植物免疫系统心理学物理载体(分子生物学)癌症研究病毒病毒载体 |
出版信息 | 出版商: Cell Press,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2014,原创研究文献占比: 94.59%,自引率:N.A., Gold OA占比: 90.58% |
平均审稿周期 | 网友分享经验:12 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development
2024-9-12
Preclinical development of hematopoietic stem cell-gene therapy for Mucopolysaccharidosis type IVB using a GLB1 transgene with enhanced therapeutic potential.
2024-9-1
Treating late-onset Tay Sachs disease: Brain delivery with a dual trojan horse protein
2024-9-1
Characterization of residual microRNAs in AAV vector batches produced in HEK293 mammalian cells and Sf9 insect cells
2024-9-1
Lipid nanoparticle-encapsulated DOCK11-siRNA efficiently reduces hepatitis B virus cccDNA level in infected mice
2024-9-1
5′ transgenes drive leaky expression of 3′ transgenes in Cre-inducible bicistronic vectors
2024-9-1
DNA Contamination Within Recombinant Adeno Associated Virus (AAV) Preparations Correlates with Decreased CD34+ Cell Clonogenic Potential
2024-9-1
Subacute liver injury in two young infants following gene replacement therapy for spinal muscular atrophy
2024-9-1
Assessment of adeno-associated virus purity by capillary electrophoresis-based western
2024-9-1
A self-complementary AAV proviral plasmid that reduces cross-packaging and ITR promoter activity in AAV vector preparations
2024-9-1
Modulation of the pharmacokinetics of soluble ACE2 decoy receptors through glycosylation
2024-9-1
Persistent tailoring of MSC activation through genetic priming
2024-9-1
Auto-expansion of in vivo HDAd-transduced hematopoietic stem cells by constitutive expression of tHMGA2
2024-9-1
Global seroprevalence of neutralizing antibodies against adeno-associated virus serotypes used for human gene therapies
2024-9-1
Engineering single-cycle MeV vector for CRISPR/Cas9 gene editing
2024-9-1
Quantification of Full and Empty Particles of Adeno-Associated Virus Vectors via a Novel Dual Fluorescence-Linked Immunosorbent Assay
2024-9-1
Combination AAV Gene Therapy with Galectin-1 and SOD1 Downregulation Demonstrates Superior Therapeutic Effect in a severe mouse model of ALS
2024-9-1
Optimal different adeno-associated virus capsid/promoter combinations to target specific cell types in the common marmoset cerebral cortex
2024-9-1
Atelocollagen supports three-dimensional culture of human induced pluripotent stem cells
2024-9-1
Gene Therapy and kidney diseases
2024-9-1
Author’s full names, departments, institutions
2024-9-1
A randomized, double-blind phase 2b trial to evaluate efficacy of ChAd63-KH for treatment of post kala-azar dermal leishmaniasis
2024-9-1
An autonucleolytic suspension HEK293F host cell line for high-titre serum-free AAV5 and AAV9 production with reduced levels of DNA impurity
2024-9-1
Humoral and cellular immune responses to AAV delivery in the airway
2024-9-1
Evaluation of a rapid multi-attribute combinatorial high-throughput UV-Vis/DLS/SLS analytical platform for rAAV quantification and characterization
2024-9-1
Assessment of Adeno-Associated Virus Purity by Capillary Electrophoresis-Based Western
2024-9-1
Cardiac Gene Delivery Using Ultrasound: State of the Field
2024-9-1
Probing recombinant AAV capsid integrity and genome release after thermal stress by mass photometry
2024-9-1
Protein is expressed in all major organs after intravenous infusion of mRNA-lipid nanoparticles in swine
2024-9-1
A pseudotyped adenovirus serotype 5 vector with serotype 49 fiber knob is an effective vector for vaccine and gene therapy applications
2024-9-1
The longitudinal kinetics of AAV5 vector integration profiles and evaluation of clonal expansion in mice
2024-9-1
Toward a large-batch manufacturing process for silicon-stabilized lipid nanoparticles: A highly customizable RNA delivery platform
2024-9-1
Systemic delivery of AAV-GCDH ameliorates HLD-induced phenotype in a glutaric aciduria type I mouse model
2024-9-1
Resolving hidden subpopulations of filled AAVs by probing capsid integrity
2024-8-29
Production of Recombinant Adeno-associated Virus 5 Using a Novel Self-Attenuating Adenovirus Production Platform
2024-8-14
Validation of high-sensitivity fluorometric assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis
2024-8-10
Lentiviral vector packaging and producer cell lines yield titres equivalent to the industry-standard four-plasmid process Stable cells for lentiviral vector manufacturing
2024-8-8
A Novel Approach to Quantitate In Vivo Biodistribution and Transduction of Adeno-Associated Viral Based Gene Therapy Using Iodine-125 and Indium-111-Labeled AAV Vector in Mice
2024-8-1
Longitudinal characterization of sub-retinal pigment epithelium deposit formation in a primary porcine tissue culture model of dry age-related macular degeneration
2024-8-1
Quantification of circulating TCR-engineered T cells targeting a human endogenous retrovirus post-adoptive transfer using nanoplate digital PCR
2024-8-1
Unlocking DOE potential selecting the most appropriate design for rAAV optimization
2024-8-1
Predictive power of deleterious single amino acid changes to infer on AAV2 and AAV2-13 capsids fitness
2024-8-1
A cellular disease model toward gene therapy of TGM1-dependent lamellar ichthyosis
2024-8-1
Lipid nanoparticle encapsulation improves effectiveness of a Delta Spike-CD40L DNA vaccine against homologous and heterologous SARS-CoV-2 challenge in Syrian hamsters
2024-8-1
CRISPR-Cas9-mediated genome editing delivered by a single AAV9 vector inhibits HSV-1 reactivation in a latent rabbit keratitis model
2024-8-1
Linker-specific monoclonal antibodies present a simple and reliable detection method for scFv-based CAR-NK cells
2024-8-1
Synergy between Lactobacillus murinus and anti-PcrV antibody delivered in the airways to promote protection against Pseudomonas aeruginosa
2024-8-1
Macrophage manufacturing and engineering with 5′-Cap1 and N1-methylpseudouridine-modified mRNA
2024-7-31
Characterization of AAV vectors: A review of analytical techniques and critical quality attributes
2024-7-30
Bio-Layer Interferometry for Adeno-Associated Virus Capsid Titer Measurement and Applications to Upstream and Downstream Process Development
2024-7-26
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远